NCT00140946View on ClinicalTrials.gov

A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)

PHASE4CompletedINTERVENTIONAL
Enrollment

546

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

October 31, 2000

Study Completion Date

October 31, 2000

Conditions
Asthma
Interventions
DRUG

MK0476; montelukast sodium/Duration of Treatment: 16 weeks

DRUG

Comparator: placebo / Duration of Treatment: 16 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00140946 - A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075) | Biotech Hunter | Biotech Hunter